Win ratio analysis of transvenous phrenic nerve stimulation to treat central sleep apnoea in heart failure

Win ratio analysis of transvenous phrenic nerve stimulation to treat central sleep apnoea in heart failure

Abstract Aims Central sleep apnoea (CSA) is present in 20–40% of heart failure (HF) patients and is associated with poor clinical outcomes and health status. Transvenous phrenic nerve stimulation (TPNS) is an available treatment for CSA in HF patients. The impact on HF outcomes is incompletely under...

Full description

Bibliographic Details
Main Authors: William T. Abraham, Olaf Oldenburg, Mitja Lainscak, Rami Khayat, Jerryll Asin, Piotr Ponikowski, Robin Germany, Scott McKane, Maria Rosa Costanzo
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:ESC Heart Failure
Subjects:
Central sleep apnoea
Heart failure
Transvenous phrenic nerve stimulation
Win ratio
Online Access:https://doi.org/10.1002/ehf2.15074

Internet

https://doi.org/10.1002/ehf2.15074

Similar Items